S&P 500   4,482.55 (+0.25%)
DOW   35,225.06 (-0.20%)
QQQ   372.26 (+0.90%)
AAPL   146.35 (+1.04%)
MSFT   307.03 (+0.93%)
FB   334.00 (+2.85%)
GOOGL   2,845.81 (+0.65%)
TSLA   872.70 (+3.52%)
AMZN   3,446.96 (+1.11%)
NVDA   222.60 (+1.82%)
BABA   167.88 (-0.07%)
NIO   39.70 (+5.28%)
CGC   13.20 (-1.12%)
GE   104.01 (-0.38%)
MU   67.21 (-0.69%)
AMD   116.64 (+4.03%)
T   25.35 (-1.36%)
F   15.54 (-1.02%)
ACB   6.92 (-1.56%)
DIS   169.84 (-3.75%)
PFE   41.34 (-0.36%)
BA   215.98 (-0.49%)
AMC   43.05 (+5.67%)
S&P 500   4,482.55 (+0.25%)
DOW   35,225.06 (-0.20%)
QQQ   372.26 (+0.90%)
AAPL   146.35 (+1.04%)
MSFT   307.03 (+0.93%)
FB   334.00 (+2.85%)
GOOGL   2,845.81 (+0.65%)
TSLA   872.70 (+3.52%)
AMZN   3,446.96 (+1.11%)
NVDA   222.60 (+1.82%)
BABA   167.88 (-0.07%)
NIO   39.70 (+5.28%)
CGC   13.20 (-1.12%)
GE   104.01 (-0.38%)
MU   67.21 (-0.69%)
AMD   116.64 (+4.03%)
T   25.35 (-1.36%)
F   15.54 (-1.02%)
ACB   6.92 (-1.56%)
DIS   169.84 (-3.75%)
PFE   41.34 (-0.36%)
BA   215.98 (-0.49%)
AMC   43.05 (+5.67%)
S&P 500   4,482.55 (+0.25%)
DOW   35,225.06 (-0.20%)
QQQ   372.26 (+0.90%)
AAPL   146.35 (+1.04%)
MSFT   307.03 (+0.93%)
FB   334.00 (+2.85%)
GOOGL   2,845.81 (+0.65%)
TSLA   872.70 (+3.52%)
AMZN   3,446.96 (+1.11%)
NVDA   222.60 (+1.82%)
BABA   167.88 (-0.07%)
NIO   39.70 (+5.28%)
CGC   13.20 (-1.12%)
GE   104.01 (-0.38%)
MU   67.21 (-0.69%)
AMD   116.64 (+4.03%)
T   25.35 (-1.36%)
F   15.54 (-1.02%)
ACB   6.92 (-1.56%)
DIS   169.84 (-3.75%)
PFE   41.34 (-0.36%)
BA   215.98 (-0.49%)
AMC   43.05 (+5.67%)
S&P 500   4,482.55 (+0.25%)
DOW   35,225.06 (-0.20%)
QQQ   372.26 (+0.90%)
AAPL   146.35 (+1.04%)
MSFT   307.03 (+0.93%)
FB   334.00 (+2.85%)
GOOGL   2,845.81 (+0.65%)
TSLA   872.70 (+3.52%)
AMZN   3,446.96 (+1.11%)
NVDA   222.60 (+1.82%)
BABA   167.88 (-0.07%)
NIO   39.70 (+5.28%)
CGC   13.20 (-1.12%)
GE   104.01 (-0.38%)
MU   67.21 (-0.69%)
AMD   116.64 (+4.03%)
T   25.35 (-1.36%)
F   15.54 (-1.02%)
ACB   6.92 (-1.56%)
DIS   169.84 (-3.75%)
PFE   41.34 (-0.36%)
BA   215.98 (-0.49%)
AMC   43.05 (+5.67%)
NYSEAMERICAN:MTNB

Matinas BioPharma Insider Trades

$1.13
+0.02 (+1.80 %)
(As of 10/18/2021 02:48 PM ET)
Add
Compare
Today's Range
$1.11
$1.16
50-Day Range N/A
52-Week Range
$0.67
$2.22
Volume21,851 shs
Average Volume2.77 million shs
Market Capitalization$242.66 million
P/E RatioN/A
Dividend YieldN/A
Beta2.37

Matinas BioPharma (NYSEAMERICAN:MTNB) Insider Buying and Selling Activity

8.10% of Matinas BioPharma's shares are owned by company executives, directors and other insiders.
Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter


Matinas BioPharma (NYSEAMERICAN MTNB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2020Adam K SternDirectorBuy20,000$0.83$16,600.001,337,399  
5/14/2020Patrick G LeporeDirectorBuy100,000$0.81$81,000.00
3/17/2020Jerome D JabbourCEOBuy10,000$0.63$6,300.00
11/25/2019Keith A KucinskiCFOBuy94,500$1.19$112,455.00
11/15/2019Patrick G LeporeDirectorBuy100,000$1.15$115,000.00
8/19/2019Adam K SternDirectorBuy10,400$0.70$7,280.00  
8/19/2019Jerome D JabbourInsiderBuy14,650$0.68$9,962.00  
8/16/2019Patrick G LeporeDirectorBuy100,000$0.72$72,000.00  
6/14/2019Adam K SternDirectorBuy15,000$0.80$12,000.00  
6/12/2019Adam K SternDirectorBuy20,000$0.80$16,000.00  
6/12/2019Jerome D JabbourInsiderBuy12,487$0.80$9,989.60  
6/10/2019Adam K SternDirectorBuy15,000$0.82$12,300.00  
6/7/2019Adam K SternDirectorBuy20,000$0.89$17,800.00  
5/31/2019Adam K SternDirectorBuy80,000$0.94$75,200.00  
5/16/2019Herbert J ConradDirectorBuy25,000$0.96$24,000.00  
9/8/2017Adam K SternDirectorBuy100,000$1.38$138,000.00793,992  
9/8/2017Roelof RongenCEOBuy5,000$1.36$6,800.003,539,416  
9/7/2017James S ScibettaDirectorBuy5,000$1.29$6,450.00418,309  
(Data available from 1/1/2013 forward)












Matinas BioPharma (NYSEAMERICAN:MTNB) Insider Trade Frequently Asked Questions

Who is on Matinas BioPharma's Insider Roster?

The list of insiders at Matinas BioPharma includes Adam K Stern, Herbert J Conrad, Jerome D Jabbour, Keith A Kucinski, and Patrick G Lepore.Learn more on MTNB's insiders

What percentage of Matinas BioPharma stock is owned by insiders?

8.10% of Matinas BioPharma stock is owned by insiders. Learn more on MTNB's insider holdings

Which Matinas BioPharma insiders have been buying company stock?

The following insiders have purchased Matinas BioPharma stock in the last 24 months: Adam K Stern ($16,600.00), Jerome D Jabbour ($6,300.00), Keith A Kucinski ($112,455.00), and Patrick G Lepore ($196,000.00).

How much insider buying is happening at Matinas BioPharma?

Insiders have purchased a total of 324,500 Matinas BioPharma shares in the last 24 months for a total of $331,355.00 bought.

This page was last updated on 10/18/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.